Skip to Main Content

Paper Details

Pharmacologic targeting of the ATX/LPA axis attenuates bleomycin-induced pulmonary fibrosis.
Pulmonary Pharmacology and Therapeutics
34
2018
AM095, ATX, Autotaxin, BLM, IPF, Idiopathic pulmonary fibrosis, LPA, LPAR, LPAR1, PF-8380, bleomycin, chronic fibrosing lung disease, chronic inflammatory and fibroproliferative disorders, lysophosphatidic acid, lysophospholipase D, pulmonary fibrosis
Author NameAffiliation
Vassilis AidinisBiomedical Sciences Research Center Alexander Fleming
  • 1 - 1

Datasets

Release 1.2